Maha KatabiCo-Founder and Managing Partner at Oxalis Capital
Maha is Managing Partner and co-founder of Oxalis Capital. She is an experienced investor in biopharma companies, with a strong track record in venture capital investing and public equities portfolio management. She financed and served on the boards of companies which received FDA drug approvals, completed public offerings, or were successfully acquired. Prior to founding Oxalis in 2018, Maha was Partner, Private Equity at Sectoral Asset Management since 2008. She formed and led a dedicated investment team and an advisory board, driving the selection and the investment process in private companies. Maha was the Portfolio Manager of a family of funds, successfully committing over $200M in assets globally in publicly listed and private healthcare companies. Prior to Sectoral, Maha was Vice-President at Ventures West Management since 2004, a leading venture capital firm focusing on technology and life sciences in Canada and the United States with $750 AUM. She started her venture capital career in 1999 as an analyst at T2C2 Capital Bio, a seed fund focused on Canadian start-ups with $100M AUM. Maha received her PhD in Pharmacology from McGill University in 1999 and is a CFA charterholder since 2011. She currently serves on the board and executive committees of not-for profits Exactis, a precision cancer therapies clinical network, and BioQuebec, an industry organization active in the healthcare industry.